Skip to search.
 FTSE 100 Down 0.04%

More On SKP.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Skyepharma PLC (SKP.L)

-LSE Ticker: 3BFNB6/ISIN: GB00B3BFNB64
297.59 Down 5.41(1.78%) 27 Feb 17:04
Add to Portfolio
Prev Close:303.00
Open:303.00
Bid:307.25
Ask:307.75
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:295.34 - 308.60
52wk Range:176.68 - 379.19
Volume:56,648
Avg Vol (3m):211,914
Market Cap:195.52m
P/E (ttm):N/A
EPS (ttm):-0.27
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):0.15
P/S (ttm):303.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :18.25
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC develops oral and inhalation pharmaceutical products. The company’s products include flutiform, a unique inhaled combination product which has been approved in 31 countries; and Pacira’s Exparel, an amide local anesthetic ... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback